Giuliano Rizzardini to Emtricitabine
This is a "connection" page, showing publications Giuliano Rizzardini has written about Emtricitabine.
Connection Strength
0.222
-
An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents. Expert Opin Pharmacother. 2019 Feb; 20(3):269-276.
Score: 0.176
-
Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trial. Lancet HIV. 2019 10; 6(10):e655-e666.
Score: 0.046